Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Vibeke, Backer"'
Autor:
Yvette Dehnes, Anders Dyreborg, Peter Hemmersbach, Vibeke Backer, Morten Hostrup, Sebastian Rzeppa, Nanna Krogh
Publikováno v:
Medicine & Science in Sports & Exercise. 49:1236-1243
This study investigated pharmacokinetics of terbutaline after single and seven consecutive days of inhalation in exercising trained men. Twelve healthy young trained men underwent two pharmacokinetic trials comparing single dose (2 mg) and seven cons
Autor:
Vibeke Backer, Morten Hostrup, Glenn A. Jacobson, Søren Jessen, Kasper Høtoft Bengtsen, Kasper Eibye
Publikováno v:
Clinical respiratory physiology, exercise and functional imaging.
Autor:
Sebastian Rzeppa, Michael Kreiberg, Søren Jessen, Morten Hostrup, Peter Hemmersbach, Vibeke Backer, Victoria Becker
Publikováno v:
Scandinavian Journal of Medicine & Science in Sports. 27:692-703
This study investigated the pharmacokinetics of inhaled terbutaline at rest and after exercise in normal and hot ambient conditions with respect to doping analysis. Thirteen trained young men participated in the study. Urine and blood samples were co
Publikováno v:
Karlsson, SL, Backer, V & Godtfredsen, N S 2018, ' Oral prednisolone for 4 days does not increase exercise tolerance in men with COPD ', Chronic Respiratory Disease, vol. 15, no. 2, pp. 220-222 . https://doi.org/10.1177/1479972317721929
Chronic Respiratory Disease
Chronic Respiratory Disease
One of the primary objectives in management of chronic obstructive pulmonary disease (COPD) is preventing decrease in lung function and reducing the annual number of acute exacerbations of COPD (AECOPD). An oral course of systemic corticosteroids is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8826e1143f75e604e7b831db32ca15d
https://curis.ku.dk/portal/da/publications/oral-prednisolone-for-4-days-does-not-increase-exercise-tolerance-in-men-with-copd(793f03b8-a60b-47de-91e1-00e03e2774f2).html
https://curis.ku.dk/portal/da/publications/oral-prednisolone-for-4-days-does-not-increase-exercise-tolerance-in-men-with-copd(793f03b8-a60b-47de-91e1-00e03e2774f2).html
Publikováno v:
The Journal of Allergy and Clinical Immunology: In Practice. 3:553-559
International guidelines recommend up-titration of anti-inflammatory treatment in asthmatic patients with poor symptom control, but patients without eosinophilic airway inflammation are less likely to benefit from this. The mannitol bronchoprovocatio
Autor:
Christoffer Haase, Peter Hemmersbach, Vibeke Backer, Sebastian Rzeppa, Morten Hostrup, Anders Kalsen
Publikováno v:
Drug Testing and Analysis. 8:613-620
The present study investigated the influence of exercise and dehydration on the urine concentrations of salbutamol after inhalation of that maximal permitted (1600 µg) on the 2015 World Anti-Doping Agency (WADA) prohibited list. Thirteen healthy mal
Autor:
Peter Hemmersbach, Vibeke Backer, Jens Bangsbo, Sebastian Rzeppa, Morten Hostrup, Anders Kalsen, Michael Auchenberg
Publikováno v:
Drug Testing and Analysis. 6:528-532
Our objective was to investigate urine concentrations of 8 mg oral salbutamol in samples collected after intense exercise in endurance athletes. Nine male endurance athletes with a VO2max of 70.2 ± 5.9 mL/min/kg (mean ± SD) took part in the study.
Publikováno v:
Scandinavian Journal of Medicine & Science in Sports. 24:814-822
There is a high prevalence of asthma and airway hyperresponsiveness (AHR) in elite athletes, which leads to a major use of beta2 -agonists. In a randomized double-blinded crossover study, we investigated the effects of combined inhalation of beta2 -a
Autor:
Lars Egholm Pedersen, Peter Hemmersbach, Kasper Eibye, Jimmi Elers, Vibeke Backer, John Henninge, Kim Dalhoff
Publikováno v:
Medicine & Science in Sports & Exercise. 45:16-22
AB Introduction: We examined urinary and serum concentrations of formoterol in asthmatic and healthy individuals after a single dose of 18 [mu]g inhaled formoterol and after repeated inhaled doses in healthy individuals. Results were evaluated using
Autor:
Nanna Krogh, Sebastian Rzeppa, Anders Dyreborg, Peter Hemmersbach, Vibeke Backer, Morten Hostrup
Publikováno v:
Dyreborg, A, Krogh, N, Backer, V, Rzeppa, S, Hemmersbach, P & Hostrup, M 2016, ' Pharmacokinetics of oral and inhaled terbutaline after exercise in trained men ', Frontiers in Pharmacology, vol. 7, 150 . https://doi.org/10.3389/fphar.2016.00150
Frontiers in Pharmacology
Frontiers in Pharmacology
Aim: The aim of the study was to investigate pharmacokinetics of terbutaline after oral and inhaled administration in healthy trained male subjects in relation to doping control. Methods: Twelve healthy well-trained young men (27 ±2 years; mean ± S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e88e02d7dd99b215b21f98a344ecb6bd
https://curis.ku.dk/portal/da/publications/pharmacokinetics-of-oral-and-inhaled-terbutaline-after-exercise-in-trained-men(511ad6bf-c5b3-4e88-9f59-b0631ef7c6cb).html
https://curis.ku.dk/portal/da/publications/pharmacokinetics-of-oral-and-inhaled-terbutaline-after-exercise-in-trained-men(511ad6bf-c5b3-4e88-9f59-b0631ef7c6cb).html